Lamotrigine Tablet, Chewable
Product Images NDC 16571-786

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 16571-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lamotrigine Fig1)

A Kaplan-Meier survival curve graph showing the cumulative proportion of patients experiencing mood episodes over time in weeks, comparing lamotrigine to placebo. The y-axis represents failure probability (%) and the x-axis shows weeks, with censored data points marked.*

FDA Label Image

Figure 2 (Lamotrigine Fig2)

Kaplan-Meier estimation chart showing the cumulative proportion of patients with mood episodes over weeks for Trial 2. The graph compares failure probability percentages between Lamotrigine and placebo groups over time, with censored data points indicated.*

FDA Label Image

Figure 3 (Lamotrigine Fig3)

This image shows a descriptive comparison of Lamotrigine tablets for oral suspension in two strengths: 5 mg tablets, which are white to off-white, debossed with 'D' on one side and '98' on the other, and 25 mg tablets, also white to off-white, debossed with 'D99' on one side and plain on the other side.*

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablets Bottle))

Lamotrigine Tablets for Oral Suspension, USP 5 mg, chewable tablets package label by Rising Pharma Holdings, Inc. The label highlights the active ingredient strength (5 mg), directions for pharmacist to dispense accompanying medication guide, and quantity of 100 tablets. Includes storage instructions and product distribution information. The label features the NDC 16571-785-01 and barcode for scanning.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Label for Lamotrigine Tablets for Oral Suspension, USP, 25 mg strength. The label includes directions for pharmacists to dispense the medication guide and indicates a package count of 100 tablets. Distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ. The label also provides storage instructions and cautions about the printed seal integrity.*

FDA Label Image

Chemical Structure (Lamotrigine Str)

Chemical structure diagram of lamotrigine showing its molecular arrangement with chlorine atoms, amino groups, and nitrogen-containing rings as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.